Enterprise Ireland:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Enterprise Ireland - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6389
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance with research and development collaboration, and connections and introductions to customers overseas. It offers funding and support for companies from entrepreneurs with business propositions for a high potential start-up through to large companies expanding their activities. EI serves healthcare, aerospace, construction, education, engineering, and other industries. The organization operates in Ireland, Australia, South Africa, India, Singapore, the Netherlands, Sweden, Poland and Germany. EI is headquartered in Dublin, Ireland.

Enterprise Ireland – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enterprise Ireland, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Enterprise Ireland, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Enterprise Ireland, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Enterprise Ireland, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Enterprise Ireland, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Enterprise Ireland, Medical Equipment, Deal Details 11
Venture Financing 11
Ostoform Raises USD1.3 Million in Venture Financing 11
Neurent Medical Raises USD11 Million in Series A Financing 12
AventaMed Raises USD2 Million in Financing 13
Radisens Diagnostics to Raise USD25 Million in Venture Financing 14
Kinesis Health Technologies Raises USD0.7 Million in Seed Financing 15
Metabolomic Diagnostics Raises USD1.8 Million in Venture Financing 16
Health Beacon Raises USD1.1 Million in Seed Financing 17
AventaMed Raises USD1.5 Million in Financing 18
Metabolomic Diagnostics Secures USD0.84 million in Venture Funding 19
Metabolomic Diagnostics Raises USD0.85 Million in Venture Financing 20
HiberGene Diagnostics Raises USD2.3 Million in Series A Venture Financing 21
Embo Medical Raises USD3.7 Million in Seed Funding 22
Metabolomic Diagnostics Raises US$1 Million In Series A Financing 23
Zinc Software Raises US$0.8 Million In Seed Financing 24
GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 25
SurgaColl Technologies Raises US$2.5 Million In Venture Financing 26
Enterprise Ireland – Key Competitors 27
Enterprise Ireland – Key Employees 28
Enterprise Ireland – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Enterprise Ireland, Medical Equipment, Key Facts 2
Enterprise Ireland, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Enterprise Ireland, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Enterprise Ireland, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Enterprise Ireland, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Enterprise Ireland, Deals By Market, 2012 to YTD 2018 8
Enterprise Ireland, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ostoform Raises USD1.3 Million in Venture Financing 11
Neurent Medical Raises USD11 Million in Series A Financing 12
AventaMed Raises USD2 Million in Financing 13
Radisens Diagnostics to Raise USD25 Million in Venture Financing 14
Kinesis Health Technologies Raises USD0.7 Million in Seed Financing 15
Metabolomic Diagnostics Raises USD1.8 Million in Venture Financing 16
Health Beacon Raises USD1.1 Million in Seed Financing 17
AventaMed Raises USD1.5 Million in Financing 18
Metabolomic Diagnostics Secures USD0.84 million in Venture Funding 19
Metabolomic Diagnostics Raises USD0.85 Million in Venture Financing 20
HiberGene Diagnostics Raises USD2.3 Million in Series A Venture Financing 21
Embo Medical Raises USD3.7 Million in Seed Funding 22
Metabolomic Diagnostics Raises US$1 Million In Series A Financing 23
Zinc Software Raises US$0.8 Million In Seed Financing 24
GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 25
SurgaColl Technologies Raises US$2.5 Million In Venture Financing 26
Enterprise Ireland, Key Competitors 27
Enterprise Ireland, Key Employees 28
Enterprise Ireland, Other Locations 29

List of Figures
Enterprise Ireland, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Enterprise Ireland, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Enterprise Ireland, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Enterprise Ireland, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Enterprise Ireland, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Enterprise Ireland, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Enterprise Ireland, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Enterprise Ireland, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Enterprise Ireland:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析
    Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lee Memorial Health System:企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Apache Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Apache Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Apache Corp (Apache) is an independent upstream energy company, which carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). It has onshore and offs …
  • Tp Icap Plc:企業の戦略・SWOT・財務分析
    Tp Icap Plc - Strategy, SWOT and Corporate Finance Report Summary Tp Icap Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • DiamondRock Hospitality Co:企業の戦略・SWOT・財務情報
    DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report Summary DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Verastem Inc (VSTM):製薬・医療:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業の財務・戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (Amara Raja) operates as a manufacturer of lead-acid storage batteries. The company operates through two sectors automotive battery and industrial battery sectors. Its automotive battery sector offers two-wheeler batteries, four-wheeler batteries and tubular batterie …
  • Sequa Petroleum NV (MLSEQ):企業の財務・戦略的SWOT分析
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company. It develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Europe, Central and West Africa and the Middle East. Sequa Petroleum has a large development and producing area in N …
  • Macro Enterprises Inc (MCR):企業の財務・戦略的SWOT分析
    Summary Macro Enterprises Inc (Macro Enterprises) is an oil and gas company that offers pipeline and facility construction and maintenance services. The company provides gathering, processing, transmission, storage and distribution of pipeline systems. It offers fabrication and installation of pipin …
  • Shoppers Drug Mart Corporation:企業の戦略・SWOT・財務情報
    Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report Summary Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PYCTX Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary PYCTX Ltd (PYCTX), formerly Phylogica Ltd is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and pep …
  • Allied Hotel Properties Inc:企業の戦略・SWOT・財務情報
    Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hyosung Corp (004800):企業の財務・戦略的SWOT分析
    Hyosung Corp (004800) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nippon Suisan Kaisha, Ltd.
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alliance Data Systems Corporation (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corporation (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • China Southern Airlines Company Limited:企業のM&A・事業提携・投資動向
    China Southern Airlines Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Southern Airlines Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Mednax Inc (MD):製薬・医療:M&Aディール及び事業提携情報
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • Crownhaitai Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Synergy Pharmaceuticals Inc:企業の戦略的SWOT分析
    Synergy Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Disproquima S.A.:企業の戦略・SWOT・財務情報
    Disproquima S.A. - Strategy, SWOT and Corporate Finance Report Summary Disproquima S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆